Insider Selling: agilon health, inc. (NYSE:AGL) Insider Sells 79,568 Shares of Stock

agilon health, inc. (NYSE:AGLGet Rating) insider Veeral Desai sold 79,568 shares of the stock in a transaction dated Thursday, April 21st. The stock was sold at an average price of $20.54, for a total value of $1,634,326.72. Following the sale, the insider now owns 278,211 shares of the company’s stock, valued at $5,714,453.94. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Shares of NYSE:AGL traded up $1.26 during mid-day trading on Monday, reaching $20.03. The company had a trading volume of 1,977,053 shares, compared to its average volume of 1,751,986. The company has a current ratio of 3.83, a quick ratio of 3.83 and a debt-to-equity ratio of 0.04. The firm has a market cap of $8.13 billion and a price-to-earnings ratio of -18.72. The company’s 50-day moving average price is $22.05 and its 200-day moving average price is $22.44. agilon health, inc. has a one year low of $14.36 and a one year high of $44.83.

agilon health (NYSE:AGLGet Rating) last posted its quarterly earnings results on Thursday, March 3rd. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.02). agilon health had a negative return on equity of 17.01% and a negative net margin of 22.17%. The company had revenue of $462.89 million during the quarter, compared to the consensus estimate of $453.53 million. On average, research analysts anticipate that agilon health, inc. will post -0.14 EPS for the current fiscal year.

Institutional investors have recently added to or reduced their stakes in the stock. West Branch Capital LLC purchased a new position in agilon health in the 3rd quarter valued at approximately $26,000. Level Financial Advisors Inc. purchased a new position in agilon health in the 4th quarter valued at approximately $27,000. O Dell Group LLC purchased a new position in agilon health in the 4th quarter valued at approximately $27,000. Royal Bank of Canada purchased a new position in agilon health in the 2nd quarter valued at approximately $50,000. Finally, Advisor Group Holdings Inc. grew its stake in agilon health by 899.4% in the 4th quarter. Advisor Group Holdings Inc. now owns 1,669 shares of the company’s stock valued at $47,000 after buying an additional 1,502 shares in the last quarter. Institutional investors and hedge funds own 93.71% of the company’s stock.

Several analysts have recently commented on AGL shares. SVB Leerink raised their target price on agilon health from $25.00 to $33.00 and gave the company an “outperform” rating in a research note on Thursday, March 31st. Zacks Investment Research raised shares of agilon health from a “sell” rating to a “hold” rating in a research report on Friday, March 4th. Guggenheim began coverage on shares of agilon health in a research report on Tuesday, March 29th. They issued a “buy” rating and a $32.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of agilon health from $30.00 to $29.00 in a research report on Tuesday, January 25th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $38.00.

About agilon health (Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Featured Stories

Insider Buying and Selling by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.